Position
Fidelity in Ani Pharmaceuticals Inc
Back to the book · All holders of ANIP
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.73M$1.79 → $2.46
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.57M | $4M | — | — | — | 0.0% |
| Q1 2026 | 2.58M | $4.62M | $1.79 | $601.5K | $16K | 0.0% |
| Q2 2026 | 2.59M | $6.35M | $2.46 | $1.73M | $7.54K | 0.0% |